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Food avoidance in irritable bowel syndrome  
leads to a nutrition-deficient diet
Introduction
Irritable bowel syndrome (IBS) is a chronic disorder that is 
characterised by abdominal pain or discomfort, and associated with 
disordered defecation, either C-IBS, D-IBS, or mixed or alternating 
symptoms of constipation and diarrhoea.1  It is estimated that IBS 
affects 3-25% of the general population. Patients with IBS can 
account for up to 30-50% of gastroenterology clinic visits.2 Treatment 
and management of the condition is often unsatisfactory, and there 
is no single curative treatment. Despite numerous reviews on IBS 
and diet, it is very difficult to give general dietary advice to patients 
with IBS. This is partly because of the complexity of the condition, 
heterogeneity of the patient population and poor understanding of 
the aetiology of the disorder. Dietary experts may play a very positive 
role in managing such patients. However, more definitive guidelines 
that outline a constructive approach for the dietitian are needed to 
treat patients with IBS. Definitive guidelines would support the unique 
skills of dietitians with regard to habitual eating and therapeutic 
dietary manipulation assessment. There is a dire need for further 
prospective research on dietary factors and IBS. Published data 
suggest that IBS symptoms may be caused or exacerbated by one or 
more dietary components in at least 25% of patients.3 Many patients 
restrict their dietary intake or eliminate certain provocative dietary 
agents in order to reduce the symptoms. The restriction of certain 
trigger foods could potentially distort macro- and micronutrient 
intake and place IBS individuals at risk of low nutrient intake.
Recent work has identified a collection of short-chain carbohydrates 
that are poorly absorbed in the small intestine, namely fermentable 
oligo-, di-, and monosaccharides and polyols (FODMAPs).4.5 These 
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include fructo-oligosaccharides, galacto-oligosaccharides and 
polyols.6  Failure to completely absorb fructose in the small intestine 
leads to its delivery into the colonic lumen, together with water, 
because of its osmotic effect. If sufficient fructose reaches the colon, 
luminal distention may occur because of the osmotic load, as well 
as rapid gas production. Potentially, this leads to bloating, abdominal 
discomfort and motility changes. These symptoms are commonly 
experienced by patients with IBS. Malabsorption of dietary fructose 
may trigger symptoms in patients with IBS and the removal of 
fructose from the diet may improve them.7
Dietary fibre, classified as soluble or insoluble, is a collective term for 
different plant substances that are resistant to digestion by human 
gastrointestinal enzymes. In the USA and the European Union, adult 
dietary fibre intake falls well below the recommended range of 
20-35g/day.8  Currently, fibre supplementation is recommended to 
patients with IBS and constipation because greater insoluble fibre 
intake results in softer and bulkier stools, thus promoting colonic 
peristalsis and easing defecation.9 Many patients with IBS self-
prescribe fibre supplements before consulting a physician because 
of the belief that alimentary habits play a significant role in their 
symptom development.10,11
Actual dietary behaviour in patients with IBS may differ from that 
of healthy controls, and has not been extensively reported. To date, 
only a few studies have assessed the dietary intake of patients with 
IBS.12-14 It is important that the latter is fully understood before any 
dietary recommendations or interventions are given. The aim of this 
study was to propectively assess the dietary intake of patients with 
IBS and to compare this with the international recommendations for 
healthy dietary intake, namely the dietary reference intakes (DRIs),15-
18 and secondly, to compare the intake of patients with IBS to that of 
healthy controls. The hypothesising assumption was that a situation 
in which subjects insist that diet or trigger foods play a part in 
symptom generation may lead to an unbalanced diet.  
Method
Study subjects
This study was a descriptive observational study, with an analytical 
component, that identified dietary risk factors that affect IBS. 
The study population was men and women recruited at a private, 
secondary care-level clinic in South Africa. Data were collected 
between July 2008 and June 2012. Subjects were screened by a 
gastroenterologist and recruited according to the study inclusion 
criteria and their willingness to participate. 
Exclusion criteria for both controls and cases included: 
•	 Being unable to give informed consent.
•	 Being younger than 18 years of age.
•	 Being unable to understand English or Afrikaans.
•	 Having had a chronic infectious disease, e.g. human immuno-
deficiency virus (HIV) or tuberculosis.
•	 Being unable to tolerate a colonoscopy procedure.
•	 Pregnant or breastfeeding mothers.
•	 Having had any previous abdominal surgery, besides an 
appendectomy, a Caesarean, tubal laproscopic cholecystectomy, 
abdominal wall hernia repair or a hysterectomy.
•	 Currently taking antibiotics or gastrointestinal motility medication.
•	 Having a history of organic intestinal disease.
In order to establish whether or not there was a difference in dietary 
intake among the studied IBS population, subjects were divided 
into subtypes: C-IBS and D-IBS. However, patients with alternating 
or mixed-type IBS were excluded for the purposes of the study. A 
diagnosis of IBS was made using Rome II criteria. Controls included 
any patients who visited the clinic for routine screening procedures, 
for example, cancer screening and to exclude IBS. They were also 
included based on their willingness to participate in the study. Cases 
and controls were neither age, nor sex matched.
Written informed consent to participate was obtained from each 
participant on enrolment. The study was approved by the Research 
Ethics Committee at Nelson Mandela Metropolitan University 
(Reference No HUMO7.70.2), and was conducted according to the 
ethical guidelines and principles of the International Declaration of 
Helsinki.
Medical information
Collected pertinent medical information included recent antibiotic 
usage, current medication, background medical history, previous 
bowel surgery, a family history of IBS, being a smoker or non-
smoker, IBS duration, IBS symptom triggers and anti-IBS-specific 
medication.
Dietary assessment
A registered dietitian explained and orientated each study subject on 
the required procedure to complete a prospective, estimated three-
day dietary record. Portion sizes were determined using household 
food measures; for example, spoons, cups, bowls and a ruler. 
The results were analysed using FoodFinder™ III, a computerised 
nutritional analysis programme for South African foods.15 To examine 
the energy and nutrient content of the subjects’ diets, the intakes 
were compared to the DRI values for adults aged 31-50 years and 
51-70 years.16-19 Micronutrient (calcium, iron, vitamin C, folate and 
vitamin A) intake was compared to the relevant DRIs. The percentage 
energy intake for protein, fat and carbohydrates was compared to 
that outlined in the UK National Diet and Nutrition Survey.20,21  The 
subjects’ diets were also analysed semi-quantitatively, using tables 
of known FODMAP content by a dietitian for fructose intake, based 
on their three-day food record. This method has been described 
elsewhere.4,7
Statistical analyses
Summary statistics were used to describe the variables. Mean 
values were used as the measures of central location for continuous 
responses, and standard deviations (SDs) as indicators of spread. 
The relationship between continuous response variables and 
nominal input variables was analysed using appropriate analysis 
of variance (ANOVA); for example, for homogenous variance among 
the groups. One-way ANOVA was utilised to assess variance. When 
heterogeneity of variances was detected with the Brown-Forsythe 
test, the data were analysed as per the Welch-Satterthwaite ANOVA. 
If the residuals were not normally distributed, a nonparametric 
ANOVA method, e.g. the Kruskal-Wallis test, was used. Multiple 
comparisons were assessed as per the Bonferroni test, provided that 
the ANOVA p-value was significant (p < 0.05).  A p-value of less than 
0.05 represented statistical significance. Statistica® version 9 was 
employed for all data analysis, and Statistical Analysis Software® 
version 9.1 for the Brown-Forsythe tests.  
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Results
Subjects’ demographics
The subjects’ demographics are shown in Table I. In total, 122 
subjects participated in the study and completed the three-day 
food record. There was a significant difference in age between 
the subjects in the three groups at baseline.  Fifty-seven per cent 
(n = 69) of the subjects were diagnosed with C-IBS and 28% 
(n = 34) with D-IBS, while 16% (n = 19) were controls (non-IBS). The 
majority (75%) of IBS subjects were female (n = 92). Nine per cent of 
the IBS subjects were male (n = 11). As expected, the majority of the 
subjects were women. There was an almost equal number of males 
(9) and females (10) in the control group. The mean body mass index 
(BMI) of the three groups fell within the overweight range.
The dietary intake of subjects with irritable bowel syndrome 
compared with that in the dietary recommendations
The mean (± SD) daily intakes for energy, macronutrients and 
selected micronutrients for the subjects are presented in Table II, and 
were compared to DRIs, recommended dietary allowances (RDAs) 
and adequate intakes, where available. Protein and carbohydrate 
intake was significantly higher than the RDAs for protein and 
carbohydrates (p-values < 0.000 and < 0.000, respectively). When 
this was expressed as the percentage energy intake from the 
diet, carbohydrate intake significantly differed to that of 
the population-based average in the UK study. However, 
protein intake did not.20,21 There is no DRI for absolute 
intake of fat. However, the percentage of energy from 
fat was significantly higher than that of the population- 
based average in the UK study.20,21 Daily total dietary 
fibre (15.13 g ± 13.11) was significantly lower (p-value 
< 0.000) than the DRI target intake of 24.76 g/day.  The 
intake of micronutrients (calcium, iron and folate) was 
significantly less than the DRI (Table II). The subgroups, 
C-IBS and D-IBS, were also compared separately to the 
RDA. No significant differences were found when the two 
groups were combined, except for iron intake. The dietary 
intake for the constipation-predominant IBS group was 
not significantly different to RDA, but it was significantly 
different for the diarrhoea-predominant IBS group (9.925 
μg ± 5.786) (p-value = 0.002).
The dietary intake of participants according to the 
different groups (constipation-predominant irritable 
bowel syndrome and diarrhoea-predominant irritable 
bowel syndrome and controls)
The data were analysed to establish whether or not 
there was any difference between the IBS subtypes 
and the control group. The mean (± SD) daily intake 
of energy, macronutrients and selected micronutrients 
are summarised in Table III. Total energy intake and 
macronutrient distribution did not differ significantly 
between the groups. The constipation-predominant IBS 
group had the highest intake of fat at 86.6 ± 62.78/day. 
There was no significant difference in dietary intake 
between the three groups
Figure 1 shows that total dietary fibre intake did not reach 
the recommended intake for all three groups, but was 
Table I: The demographics of the 122 subjects
All subjects
(n = 122)
Controls
(n = 19)
C-IBS
(n = 69)
D-IBS
(n = 34)
p-value
Age in years 
(mean ± SD)
48.29 ± 13.56 56.9 ± 13.66 47.2 ± 12.45 45.7 ± 14.14 0.008
BMI in kg/m2
(mean ± SD)
27.82 ± 6.88 26.80 ± 7.48 28.07 ± 6.81 27.89 ± 6.81 0.779
Gender (male/female) 20/102 9/10 4/65 7/27 0.000
BMI: body mass index, C-IBS: constipation-predominant irritable bowel syndrome, D-IBS: diarrhoea-predominant irritable bowel syndrome, SD: standard deviation
Table II: The daily energy and nutrient intake of the irritable bowel syndrome group 
(combined constipation-predominant irritable bowel syndrome (C-IBS) and diarrhoea-
predominant irritable bowel syndrome (D-IBS) (mean ± standard deviation) compared with 
dietary reference intake (recommended daily allowance or adequate intake where available)
Total daily intakes IBS participants 
(n = 103)
RDA/AI p-value
Energy intake (MJ) 8.63 ± 4.7 8.9a 0.560
Carbohydrates (g) 216.37 ± 101.86 130b < 0.000
Protein (g) 88.01 ± 119.04 47.1c < 0.000
Fat (g) - -
% energy from carbohydrates 44.68 ± 9.54 47d 0.015
% energy from protein 15.7 ± 6.51 15d 0.281
% energy from fat 36.54 ± 7.77 33d < 0.000
Total dietary fibre (g) 15.13 ± 13.11 24.76e < 0.000
Calcium (mg) 619.33 ± 308.04 1077.67f < 0.000
Iron (mg) 11.26 ± 9.38 13.24g 0.035
Vitamin C (mg) 93.3 ± 89.68 76.6h 0.061
Folate (μg) 186.23 ± 103.01 400i < 0.000
Vitamin A (μg) 712.86 ± 600.45 721.36j 0.886
AI: adequate intake, IBS: irritable bowel syndrome, RDA: recommended daily allowance
a: Estimated average requirement for energy intake, weighted for the study population18 
b: Recommended dietary intake for carbohydrates18
c: Recommended dietary intake for protein, weighted for the study population. The recommended daily allowance for 
protein for men and women aged 31-70 years is 56 g/day and 46 g/day, respectively18
d: Population average, based on the UK survey22
e: Adequate intake for total dietary fibre, weighted for the study population. Adequate intake of total fibre for men aged 
31-50 years and 51-70 years is 38 g/day and 30 g/day, respectively. Adequate intake of total fibre for women aged 
31-50 years and 51-70 years, is 25 g/day and 21 g/day, respectively18
f: Adequate intake for calcium, weighted for the study population. Adequate intake of calcium for men and women aged 
31-50 years is 1 000 mg/day, and for men and women aged 51-70 years, 1 200 mg/day19
g: Recommended daily allowance for iron, weighted for the study population. The recommended daily allowance of iron 
for men aged 31-70 years is 8 mg/day. The recommended daily allowance of iron for women aged 31-50 years and 
51-70 years is 18 mg/day and 8 mg/day, respectively19
h: Recommended daily allowance for vitamin C, weighted for the study population. The recommended daily allowance 
for men aged 31-70 years is 90 mg/day and for women aged 31-70 years, 75 mg/day20
i: Recommended daily allowance for folate19
j: Recommended daily allowance for vitamin A, weighted for the study population. The recommended daily allowance 
for men aged 31-70 years is 900 μg/day, and for women aged 31-70 years, 700 μg/day19
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higher in the control group than it was in the IBS groups. The IBS 
groups had a poorer intake of fibre compared to that in the controls. 
Although it was not statistically significant, there was a trend for the 
constipation-predominant IBS group to have the poorest intake of 
soluble fibre, when compared to both the D-IBS and control groups 
(p-value = 0.055). 
Fructose intake 
Fructose intake was assessed in n = 115 subjects [consti-pation-
predominant IBS (n = 64), D-IBS (n = 33) and controls (n = 18)]. 
The total number of fructose serves per day was not statistically 
significant among the three groups [constipation-predominant 
IBS (2.68 ± 1.68), D-IBS (2.15 ± 1.86) and controls (3.17 ± 2.39), 
p-value = 0.157]. The diarrhoea-predominant IBS participants had 
the lowest intake of fructose (in excess of glucose) per day. The high 
fructose intake in all three groups was mostly attributed to the intake 
of high corn starch-containing soda or fizzy drinks (the fructose to 
glucose ratio is 55:45), and secondly to fruits with a high fructose 
content.
Discussion
The purpose of this observational study was to assess the dietary 
intake of subjects with IBS and to establish whether or not any 
alteration in dietary intake impacted on nutrient intake, or whether 
or not any dietary intake could explain the presentation of IBS 
symptoms.  
The results of this study revealed nutritional inadequacies in the IBS 
population. The subjects in this study reported on the consumption 
of a diet with a macronutrient composition that met recommended 
intakes, with the exception of total dietary fibre intake, which fell 
significantly below the recommendation. The latter finding is similar 
to that of Park et al.8 In that study, it was observed that American and 
European diets contain inadequate fibre. A further study by Park et 
al also highlighted poor fibre intake in a group of women with IBS.22 
A randomised, multicentre, open clinical trial23 compared the effect 
of a partially hydrolysed guar gum (PHGG) supplement (soluble fibre) 
with that of a wheat bran supplement (insoluble fibre) on a large 
number of patients with C-IBS and D-IBS. Significant improvements 
in bowel movement normalisation and abdominal pain relief were 
found in patients receiving the 5 g/day PHGG, compared to those 
receiving the 30 g/day of wheat bran. In a recent systematic review 
Table III: The daily energy and nutrient intake of the study population (mean ± standard deviation), constipation-predominant irritable bowel syndrome, 
diarrhoea-predominant irritable bowel syndrome and controls
Intake D-IBS (n = 34) C-IBS (n = 69) Controls (n = 19) p-value
Energy kJ (kcal) 8 036.44 ± 3 552.91
(1 913 ± 846)
8 928.9 ± 5 166.18
(2 126 ± 1 230)
7 808.65 ± 2 128.66
(1 859 ± 507)
0.476
Carbohydrates (g) 205.57 ± 89.61 221.7 ± 107.60 219.07 ± 58.16 0.710
Protein (g) 70.23 ± 38.15 96.77 ± 142.53 75.21 ± 26.43 0.466
Fat (g) 78.92 ± 42.39 86.8 ± 62.78 68.97 ± 27.52 0.411
Carbohydrates (% energy) 44.16 ± 8.49 44.93 ± 10.07 49.17 ± 8.82 0.157
Protein (% energy) 14.81 ± 3.42 16.13 ± 7.57 16.32 ± 3.17 0.541
Fat (% energy) 36.98 ± 8.37 36.31 ± 7.51 32.91 ± 7.78 0.167
Saturated fatty acids 25.75 ± 12.31 29.32 ± 26.97 22.31 ± 10.38 0.417
Polyunsaturated fatty acids 18.61 ± 10.51 20.77 ± 11.98 15.06 ± 8.23 0.132
Monounsaturated fatty acids 26.90 ± 16.5 28.47 ± 25.11 24.19 ± 10.93 0.733
Cholesterol (mg) 246.03 ± 139.5 333.36 ± 407.73 250.01 ± 132.18 0.345
Total dietary fibre (g) 15.14 ± 9.22 15.13 ± 14.72 17.50 ± 6.04 0.746
Insoluble dietary fibre (g) 4.36 ± 2.91 3.66 ± 2.17 5.16 ± 3.16 0.064
Soluble dietary fibre (g) 3.96 ± 3.51 2.83 ± 1.66 3.93 ± 2.26 0.055
Calcium (mg) 572.60 ± 358.34 642.35 ± 279.98 662.68 ± 269.45 0.464
Iron (mg) 9.92 ± 5.79 11.92 ± 10.70 11.47 ± 5.06 0.561
Vitamin C (mg) 81.76 ± 71.45 98.97 ± 97.4 123.47 ± 108.54 0.293
Folate (μg) 177.46 ± 76.13 190.54 ± 114.22 189.32 ± 54.14 0.808
Vitamin A (μg) 582.04 ± 419.65 777.32 ± 665.26 899.11 ± 694.20 0.154
C-IBS: constipation-predominant irritable bowel syndrome, D-IBS: diarrhoea-predominant irritable bowel syndrome
*
* *
*
Controls C-IBS
30
25
20
15
10
5
0
D-IBS DRI
Total dietary fibre Insoluble dietary fibre Soluble fibre
* p-value < 0.05
g/
da
y
C-IBS: constipation-predominant irritable bowel syndrome, D-IBS: diarrhoea-predominant irritable 
bowel syndrome, DRI: dietary reference intake 
*:p-value < 0.05 was significantly different to dietary reference intake
Figure 1: The dietary fibre intake of constipation-predominant irritable 
bowel syndrome, diarrhoea-predominant irritable bowel syndrome and the 
controls, compared to the dietary reference intake
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and meta-analysis of 12 studies that compared fibre with placebo or 
no treatment in 591 patients, ispaghula husk (soluble fibre) and not 
wheat bran, was shown to be an effective treatment for IBS.24 The 
latter finding  highlights the beneficial effects of increasing soluble 
fibre, particularly PHGG, in patients with C-IBS and D-IBS.  
Short-chain fatty acids (SCFAs) are linked to a decreased likelihood 
of IBS.24,25 The rate and amount of SCFA production depends on 
the species and number of microflora present in the colon, the 
substrate source and gut transit time.26 The poor fibre intake seen 
in the participants with IBS in this study would influence SCFA 
production. SCFAs aid in the relaxation of resistance vessels in the 
colonic vasculature, help support blood flow to the liver and colon,27 
and enhance colonic muscular contraction, thereby contributing to 
laxation and relief from constipation.28  
Therefore, SCFAs may alleviate certain IBS symptoms, particularly 
if altered central nervous system sensory processing and disturbed 
autonomic nervous system regulation are aetiological factors for 
IBS.29 In a study by Tana et al, patients with IBS showed significantly 
higher levels of acetic, propionic, and total organic, acid, than that in 
controls.30 Higher organic acid levels were also associated with more 
severe symptoms and impaired quality of life.  
Recent published data strongly suggest that dysbiosis in the 
microbiota of patients with IBS patients plays an important role in 
the presentation of IBS. The faecal microbiota of patients with IBS 
differs significantly to those of healthy subjects.31 Tana et al showed 
that patients with IBS had significantly higher counts of Veillonella 
and Lactobacillus, but did not differentiate these findings between 
IBS subtypes.30 Codling et al found that there was significantly more 
variation in the gut microbiota of healthy volunteers than in those of 
patients with IBS, and concluded that the gut microbiota within the 
colon are influenced by the disease in IBS.32 Owing to the positive 
role that fibre plays in SCFA production and gut microbiota symbiosis, 
the recommendation to increase soluble fibre intake, in particular, in 
this group of patients with IBS may be beneficial.
The C-IBS group had the highest BMI, although it was not significantly 
different from that of the diarrhoea-predominant IBS and control 
groups. A potential relationship exists between overweight/obesity 
and constipation. A few studies have reported on an association 
between obesity and constipation.33,34
Inflammation may play a role in functional gastrointestinal 
disorders. It has been hypothesised that obesity may increase the 
risk of functional gastrointestinal disorders, owing to the release 
of proinflammatory cytokines. Secondly, the association could 
be attributed to excess abdominal fat exerting extra pressure on 
the colon, leading to slower mobility and possible metabolism. Or 
alternately, the longer that fermentable food remains in the colon, 
the longer the gut microbiota can ferment it and release extra energy, 
contributing to obesity. The higher fat content of the C-IBS subjects 
diets could have aggravated the development of symptoms in this 
subset of subjects. Dietary advice to decrease dietary fat content 
may be valuable.35  
To date, there has been no evidence that patients with functional 
bowel symptoms consume more FODMAPs than those without 
symptoms.36 In this study, it was found that subjects with IBS 
consumed a very comparable amount of fructose to that of healthy 
controls. The number of fructose serves per day eaten by IBS subjects 
was similar to that found by Croagh et al.37 Fructose is a common 
part of the Western diet. FODMAPs are not the cause of functional 
bowel disorders, but may be a useful tool in the dietary treatment 
and management of IBS.38 The efficacy of a dietitian-delivered, low-
FODMAP diet has been demonstrated in published studies. Reducing 
the dietary intake of FODMAPS has been shown to lead to a marked 
improvement in bowel symptoms.7,39,40 In view of the latter findings, 
it is probable that the IBS subjects in this study would benefit 
from dietary counselling aimed at a reduction in fructose intake, 
particularly as the majority of fructose consumed by the subjects 
was from high-fructose corn syrup in sweetened cold drinks.  
The IBS subjects in this study had a poor micronutrient intake of 
calcium, folate and iron. However, the symptoms for a poor calcium, 
folate and iron intake are not synonymous with IBS symptoms. 
Hence, it would appear that subjects altered or restricted their diets 
in order to manage their IBS symptoms, which may have adversely 
affected their nutrient intake.  
The D-IBS group showed an insufficient intake of vitamin A. This is 
similar to the findings of Aller et al.41 Vitamin A and its derivatives 
have been shown to regulate the growth and differentiation 
of gastrointestinal epithelial cells. Amit-Romach et al showed 
that a vitamin A-deficient diet compromised the function of the 
gastrointestinal mucosal epithelial barrier.42 This may be one of the 
underlying mechanisms in the aetiology of diarrhoea-predominant 
IBS.
There are inherent limitations in utilising an estimated three-day 
food record to assess nutritional intake. This prospective method of 
dietary assessment may be influenced by the presence of active IBS 
symptoms, which could have distorted usual dietary intake. Hence, 
it is important to concurrently assess symptom severity. Further 
research to assess the validity and reliability of the three-day food 
record or diary in patients with IBS would be useful.  
Lastly, supplementation usage was recorded, but not reported, 
because less than 10% of subjects used supplements (varying 
brands). 
Conclusion
The findings of this study suggest that IBS may have an impact 
on the dietary intake of patients with IBS. Therefore, patients with 
IBS should be assessed for inadequate intake of key nutrients, 
specifically fibre. Dietary advice should be given and supplements 
recommended, where appropriate. Patients with IBS may be at risk 
of low micronutrient intake.
All three groups demonstrated a poor fibre intake, which is a growing 
concern in the Westernised diet.43 There were more similarities 
than differences in the IBS groups and controls with regard to 
the consumption of foods that have frequently been implicated to 
worsen IBS symptoms. The lack of differences in dietary intake may 
be the result of an absence of awareness or education that certain 
food may worsen symptoms, namely, fructose. This prospective 
study evaluated and compared the dietary content in C-IBS and 
D-IBS subjects, and found the diets to be deficient in micronutrients 
and fibre. The IBS subjects may have adjusted their diets to alleviate 
symptom development, and this may have resulted in nutritionally 
deficient diets.
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Patients with C-IBS were found to have a higher fat intake, while 
those with D-IBS had an insufficient vitamin A intake, both of which 
could have contributed to their IBS symptoms. It is recommended 
that patients with C-IBS and D-IBS are managed differently as their 
clinical presentation may vary in pathogenesis. Further research on 
the cause-effect relationship between dietary composition and the 
resultant SCFAs or gut microbiota is needed. The role that the organic 
acids and gut microbiota composition play in the aetiology of IBS 
symptoms has yet to be strongly demonstrated. There is a dire need 
for research that demonstrates a strong relationship between dietary 
composition, microbiota and SCFAs found in patients with either 
C-IBS or D-IBS. The role that diet plays with regard to microbiota 
and their by-products, and to what extent this may contribute to the 
pathogenesis of C-IBS and D-IBS, also requires further exploration.
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